Published • loading... • Updated
Colombia Approves CRISPR-Based Blood Test for Tuberculosis
Summary by Clinical Lab Products
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Colombia Approves CRISPR-Based Blood Test for Tuberculosis
IntelliGenome receives regulatory clearance and partners with Velez Lab for distribution of its molecular diagnostic assay. Colombia’s National Institute for Food and Drug Surveillance (INVIMA) has granted sanitary registration for the CRISPR-TB Blood Test Kit, allowing for the commercialization of the molecular diagnostic throughout the country. The registration, issued under INVIMA Registration No. 2026RD-0009793, authorizes the importation an…
4th of July SaleGet 40% off Vantage subscriptions for yourself or a friend.Get Started
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
